Your browser doesn't support javascript.
loading
C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients.
Zhang, Yiyang; Lu, Lianghe; He, Zhangping; Xu, Zhishen; Xiang, Zhicheng; Nie, Run-Cong; Lin, Wenping; Chen, Wenxu; Zhou, Jie; Yin, Yixin; Xie, Juanjuan; Zhang, Youcheng; Zheng, Xueyi; Zhu, Tianchen; Cai, Xiaoxia; Li, Peng; Chao, Xue; Cai, Mu-Yan.
Afiliación
  • Zhang Y; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Lu L; Department of Endoscopy, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • He Z; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xu Z; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xiang Z; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Nie RC; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Lin W; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Chen W; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhou J; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yin Y; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xie J; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang Y; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zheng X; Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhu T; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cai X; Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li P; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Chao X; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cai MY; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Front Immunol ; 13: 808101, 2022.
Article en En | MEDLINE | ID: mdl-35185894
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Biomarcadores de Tumor / Carcinoma Hepatocelular / Inhibidores de Puntos de Control Inmunológico / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Biomarcadores de Tumor / Carcinoma Hepatocelular / Inhibidores de Puntos de Control Inmunológico / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China